跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MS CONTIN 10mg - TGA Drug Approval Details
Approvals
/
TGA
/
MS CONTIN 10mg
Approved
STANDARD
MS CONTIN 10mg
Mundipharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
98ecd57b8e68aa82
Company
Mundipharma Pty Ltd
Type
Standard
Approval Details
Approval Id
98ecd57b8e68aa82
Product Name
MS CONTIN 10mg
Artg Id
210776
Artg Name
MS CONTIN morphine sulfate pentahydrate 10mg modified release tablet blister pack
Sponsor
Mundipharma Pty Ltd
Company Detail Path
/organization/mundipharma-pty-ltd
Artg Date
2013-06-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-06123-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-06782-3
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
98ecd57b8e68aa82
Type
Standard
Back to TGA Approvals